News | October 27, 2025
Zydus receives approval from Health Canada for Mesalamine suppositories
Mesalamine suppositories are indicated for the treatment of mildly to moderately active ulcerative proctitis
Mesalamine suppositories are indicated for the treatment of mildly to moderately active ulcerative proctitis
Liothyronine tablets will be manufactured at Zydus' plant in Ahmedabad SEZ
Deflazacort oral suspension is indicated for treating Duchenne Muscular Dystrophy in patients 5 years of age and older
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
The facility has been classified as Voluntary Action Indicated
He has been associated with the Zydus Group since 2009
Zydus will work closely with the USFDA to address and resolve the observations in an expeditious manner
Under the terms of this agreement, Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
Subscribe To Our Newsletter & Stay Updated
